Hubert Yin

  • hubert
    More than 23.5 million Americans suffer from autoimmune diseases like rheumatoid arthritis, scleroderma and lupus, in which an overzealous immune response leads to pain, inflammation, skin disorders and other chronic health problems. The conditions
  • BioFrontiers Hubert Yin is focused on toll-like receptors that may play a role in new therapies for neurodegenerative diseases.
    If you believe the common adage that you are only using ten percent of your brain, while the other ninety percent remains untapped potential, you are about to be surprised. It’s true that about ten percent of your nervous system is made up of hard-
  • BioFrontiers Hubert Yin is focused on toll-like receptors that may play a role in new cancer therapies.
    BioFrontiers’ Hubert Yin is unlocking the power of toll-like receptorsHubert Yin has been thinking about one type of cell receptor since he joined the BioFrontiers Institute, and it is a receptor worthy of that kind of time. Yin, an Associate
  • Hubert Yin is one of three BioFrontiers scientists who received state grants to enable commercialization.
    BioFrontiers faculty receive commercialization grants from the State of ColoradoTen CU research projects were recently selected to receive grants through Colorado’s Bioscience Discovery Evaluation Grant Program (BDEG-Co). The State of Colorado
  • Biofrontiers scientist, Hubert Yin, is focused on making morphine more effective and less addictive.
    A University of Colorado Boulder-led research team has discovered that two protein receptors in the central nervous system team up to respond to morphine and cause unwanted neuroinflammation, a finding with implications for improving the efficacy of
  • Biofrontiers Institute scientist, Hang (Hubert) Yin’s, focus on the Epstein Barr virus is leading him to a greater understanding of how cancer invades cells. Photo courtesy: Glenn Asakawa, University of Colorado Boulder
    Stopping cancer's knock on the doorAs a self-proclaimed “science nerd” in a Beijing high school, Hubert Yin considered biochemistry to be the ultimate in cool. It was the only science, he felt, that was capable of explaining what he thought was the
  • Biofrontiers scientist, Hubert Yin, is using fluorescent biomarkers to develop a better screening method for cancer.
    Biomarkers light the way to cancer diagnosis  In an 18-year study released this summer by the National Cancer Institute, widespread screening for ovarian cancer was found to be ineffective in catching the disease. In fact, the screening often
  • hubert yin
    CIMB scientist, Hubert Yin, describes how he is stepping out of his comfort zone in search of a better understanding of cancer. Read more in this interview.
  • Hubert Yin
    A University of Colorado cancer researcher secured a $750,000, highly competitive Stand up to Cancer Innovative Research Grants. Hang "Hubert" Yin, assistant professor of chemistry and biochemistry at CU-Boulder, will receive the grant over a
  • Hubert Yin, image courtesy University of Colorado
    Two University of Colorado at Boulder faculty members are among 33 researchers selected by the Howard Hughes Medical Institute of Chevy Chase, Md., to participate in a $40 million pilot program to pursue large, collaborative and potentially
Subscribe to Hubert Yin